Tension-type headache: an update on mechanisms and treatment

被引:61
作者
Jensen, R [1 ]
Olesen, J [1 ]
机构
[1] Univ Copenhagen, Glostrup Hosp, Dept Neurol N01, DK-2600 Glostrup, Denmark
关键词
D O I
10.1097/00019052-200006000-00009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tension-type headache represents one of the most costly diseases in modern society because of its very high prevalence. Very little research on this disease has actually been carried out, and knowledge about key pathophysiological issues such as the nature and site of the noxious stimulus is surprisingly limited. As a result of this and the lack of scientific interest from the medical field, treatment is widely non-specific, very often ineffective and consists mainly of simple analgesics. The only new strategy is the pericranial injection of botulinum toxin. If current progress in our understanding of the mechanisms of tension-type headache continues, this may lead to greater scientific interest and the development of more specific and more effective drugs in the future. Curr Opin Neurol 13:285-239 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 57 条
[1]   Muscle hardness in patients with chronic tension-type headache: relation to actual headache state [J].
Ashina, M ;
Bendtsen, L ;
Jensen, R ;
Sakai, F ;
Olesen, J .
PAIN, 1999, 79 (2-3) :201-205
[2]   Measurement of muscle hardness: a methodological study [J].
Ashina, M ;
Bendtsen, L ;
Jensen, R ;
Sakai, F ;
Olesen, J .
CEPHALALGIA, 1998, 18 (02) :106-111
[3]   Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial [J].
Ashina, M ;
Lassen, LH ;
Bendtsen, L ;
Jensen, R ;
Olesen, J .
LANCET, 1999, 353 (9149) :287-289
[4]   Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache [J].
Ashina, M ;
Bendtsen, L ;
Jensen, R ;
Lassen, LH ;
Sakai, F ;
Olesen, J .
BRAIN, 1999, 122 :1629-1635
[5]   Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache [J].
Ashina, M ;
Bendtsen, L ;
Jensen, R ;
Ekman, R ;
Olesen, J .
PAIN, 1999, 83 (03) :541-547
[6]   PLASMA AND CEREBROSPINAL-FLUID BETA-ENDORPHIN IN CHRONIC TENSION-TYPE HEADACHE [J].
BACH, FW ;
LANGEMARK, M ;
SECHER, NH ;
OLESEN, J .
PAIN, 1992, 51 (02) :163-168
[7]   Decreased pain detection and tolerance thresholds in chronic tension-type headache [J].
Bendtsen, L ;
Jensen, R ;
Olesen, J .
ARCHIVES OF NEUROLOGY, 1996, 53 (04) :373-376
[8]   Qualitatively altered nociception in chronic myofascial pain [J].
Bendtsen, L ;
Jensen, R ;
Olesen, J .
PAIN, 1996, 65 (2-3) :259-264
[9]   Exteroceptive suppression of temporal muscle activity is normal in chronic tension-type headache and not related to actual headache state [J].
Bendtsen, L ;
Jensen, R ;
Brennum, J ;
ArendtNielsen, L ;
Olesen, J .
CEPHALALGIA, 1996, 16 (04) :251-256
[10]   A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache [J].
Bendtsen, L ;
Jensen, R ;
Olesen, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03) :285-290